AzTrials
AzTrials

Genu ValgumNCT04377373

Correlation Between Sacral Angle and Lumbar Range of Motion in Women With Genu Valgum

An observational study of Genu Valgum, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many patients with genu valgum present with postural changes, such as: internal rotation of the tibial and femoral axes, anteversion of the iliac bones, increased lumbar lordosis, thoracic hyperkyphosis and cervical hyperlordosis. Such pathomechanical changes may interfere with lumbar range of motion. Read more about this study

Who is it for?
Ages 18 to 25 years, women only
Conditions the study is for
Genu Valgum
How many people
64 participants
Where
1 siteEgypt
Study dates
14 Apr 2019to 5 Sep 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: Female with bilateral genu valgum with age range 18-25 and BMI≥ 30 (kg/m2)

Who may be able to join

  • Female with bilateral genu valgum (Q angle> 20 degrees.
  • Age ranges from 18-25 years old.
  • BMI ≥ 30 (kg/m2)

Who cannot join

  • Previous lumbar surgery
  • lumbar spine fracture
  • Spondylolisthesis
  • Foraminal or extra foraminal lumbar disc herniation
  • spinal tumors, and bone metabolic diseases 6 - Knee surgeries

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Cairo university

    Giza

Other trials in Egypt

About this study

Many patients with genu valgum present with postural changes, such as: internal rotation of the tibial and femoral axes, anteversion of the iliac bones, increased lumbar lordosis, thoracic hyperkyphosis and cervical hyperlordosis. Such pathomechanical changes may interfere with lumbar range of motion. Investigators of this study try to answer the following question: is there a relationship between sacral angle and lumbar range of motion in women with bilateral genu valgum. the results of this study will help professionals to plan a proper treatment program for patients with genu valgum.

Read the detailed description

Sixty four female participants were under the following procedures:

  • Screening for genu valgum via postural assessment from frontal view, then measuring the Q angle bilaterally.
  • Patients with Q-angle >20 degress were under the following procedures:
  1. Full-Length AP standing X-ray,then the investigators measured the hip-knee angle (the angle between the mechanical axis of the femur and the tibia). It will be obtained by connecting the center of the femoral head to the midpoint of the tibial eminential spine in a line tangential to the femoral condyles, and another line from here to the centre of the trochlea tali.

B-Lumbo-sacral X-ray lateral view was done at the time and the sacral angle was the measured by Ferguson´s technique in degrees using a protractor and this was the sacral angle.

C- During the same session, trunk range of motion was measured by Modified schober test D- Collected data were taken for statistical analysis.

Conditions
Genu Valgum
Medical subject headings
Genu Valgum

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sacral angle

    After X-ray lateral view for lumbo-sacral spine, the investigators used a 30 cm long transparent ruler to measure the sacral angle on the X-ray film.

    Two lines were drawn, the first line along the superior margin of the sacrum, and the second line was the horizontal line.

    The acute angle between 2 lines(sacral angle) was measured in degrees using a protractor.

    Measured: 30 minutes

  2. Lumbar range of motion measured by Modified Shobber test

    • Patient was directed to stand with the back exposed.
    • Dimples of Venus (posterior superior iliac spine) was determined and was marked by pertinent marker.
    • Using tape measurement, the researcher marked a point 5 cm below and 10 cm above marked dimples (total marked area was 15 cm).
    • Then the subject was asked to lean forward without bending the knees.
    • The distance between 2 points was measured (D), then the ROM was determined by the following equation; ROM = D -15.

    Measured: 15 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 May 2020
  2. Study start14 Apr 2019
  3. Primary completion15 Aug 2019
  4. Study completion5 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
64 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04377373
Sponsor's protocol ID
P.T.REC/012/002300
Status last verified
May 2020
First submitted
6 Sep 2019
Last updated
6 May 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Genu Valgum, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 May 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sacral angle (time frame: 30 minutes). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in